Want to see TSE:NSHS full AI Analyst Report?
NSHS Stock Chart & Stats
C$0.02
C$0.00(0.00%)
At close: 4:00 PM EDT
C$0.02
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.02 - C$0.04
Previous CloseN/A
Volume1.00K
Average Volume (3M)9.76K
Market Cap
C$205.50K
Enterprise ValueC$0.37
Total Cash (Recent Filing)C$1.88K
Total Debt (Recent Filing)C$57.14K
Price to Earnings (P/E)―
Beta-3.18
Next Earnings
Aug 31, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding10,275,205
10 Day Avg. Volume800
30 Day Avg. Volume9,759
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)-0.14
Price to Sales (P/S)0.00
P/FCF Ratio-8.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Narrowing Cash BurnA multi-year reduction in cash outflows indicates management has been able to slow burn and improve spending efficiency. That trend, if sustained, lengthens runway, reduces near-term financing pressure and materially improves the firm's ability to execute R&D or strategic milestones over months.
Low Absolute Debt BurdenModest nominal debt limits fixed financing costs and reduces immediate solvency pressure. For an early-stage biotech this structural light leverage gives flexibility to pursue equity or partnership funding without heavy interest obligations that could accelerate distress under prolonged losses.
Lean Operating FootprintA very small headcount keeps fixed operating expenses low and makes the company more nimble to prioritize core programs. This structural lean profile helps preserve cash, lowers ongoing burn, and simplifies operational scaling decisions as the business advances development milestones.
Bears Say
Pre-revenue ProfileWith zero reported revenue the company lacks internal cash generation and must rely on external funding or partnerships. This structural absence of product sales raises execution risk, lengthens time to self-sufficiency, and reduces visibility into sustainable profitability over months.
Deeply Negative Shareholders’ EquityPersistently negative equity reflects accumulated deficits that weaken the capital structure. This structural imbalance constrains borrowing capacity, elevates going-concern and refinancing risk, and typically necessitates dilutive recapitalization or asset sales to restore solvency.
Ongoing Operating Losses And Cash BurnConsistent negative operating and free cash flows mean the business is not self-funding and depends on external financing to sustain operations. Over the medium term this undermines program continuity and increases the likelihood of funding-driven delays or strategic compromises.
NSHS FAQ
What was NanoSphere Health Sciences Inc’s price range in the past 12 months?
NanoSphere Health Sciences Inc lowest stock price was C$0.02 and its highest was C$0.04 in the past 12 months.
What is NanoSphere Health Sciences Inc’s market cap?
NanoSphere Health Sciences Inc’s market cap is C$205.50K.
When is NanoSphere Health Sciences Inc’s upcoming earnings report date?
NanoSphere Health Sciences Inc’s upcoming earnings report date is Aug 31, 2026 which is in 13 days.
How were NanoSphere Health Sciences Inc’s earnings last quarter?
Currently, no data Available
Is NanoSphere Health Sciences Inc overvalued?
According to Wall Street analysts NanoSphere Health Sciences Inc’s price is currently Overvalued.
Does NanoSphere Health Sciences Inc pay dividends?
NanoSphere Health Sciences Inc does not currently pay dividends.
What is NanoSphere Health Sciences Inc’s EPS estimate?
NanoSphere Health Sciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NanoSphere Health Sciences Inc have?
NanoSphere Health Sciences Inc has 10,275,205 shares outstanding.
What happened to NanoSphere Health Sciences Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NanoSphere Health Sciences Inc?
Currently, no hedge funds are holding shares in TSE:NSHS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NanoSphere Health Sciences Inc
NanoSphere Health Sciences Inc. is a nano-biotechnology enterprise operating in the United States and Canada, specializing in the provision of biologically active compounds. The company's primary offering is the NanoSphere Delivery System, an innovative platform that harnesses nanotechnology to optimize the bio-delivery of supplements, nutraceuticals, and over-the-counter medications. This advanced technology serves diverse sectors including cannabis, pharmaceuticals, and animal health. Founded in 2005, the company maintains its headquarters in Vancouver, Canada.